Biden Administration Responds to IV Fluid Supply Disruptions with Wartime Powers
IV Fluid Supply Disruptions Prompt Biden Administration Action
The recent disruptions in IV fluid supply, exacerbated by Hurricane Helene, have resulted in significant shortages across the United States. As the storm damaged operations at Baxter International’s North Cove facility, which is responsible for producing approximately 60% of the nation's IV fluids, the Biden administration has invoked the Defense Production Act to expedite recovery efforts.
Key Impacts of the Supply Chain Crisis
- Hospitals are currently rationing supplies and postponing surgeries due to critical shortages.
- The FDA has imported products from five international facilities to alleviate the supply constraints.
- Increased production is being pursued by other manufacturers to help fill the gaps.
Federal Support and Industry Response
The U.S. Department of Health and Human Services is working closely with Baxter, providing priority access to necessary materials for facility clean-up and production restoration. The administration emphasizes the importance of ensuring medical supplies are available, aiming for a swift restart of output.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.